EXACT Sciences Corp. (EXAS)

Last Three Months

29-Dec-19 -- 28-Mar-20

Time Period:

Three Months
|
Year

($2.85M) Net Amount

Buy:	0	--
Sell:	($2.85M)	$100.00 - $100.68

Company Sentiment

Biotechnology

Drugs

Sentiment Breakdown by Insider

1

(3)

0

(2)

1

(1)

30

0

4

+1

0

+2

0

+3

Two Year Chart

29-Mar-18 -- 28-Mar-20

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Mar-20 7:13 PM View:	28-Feb-20 Planned Option Sale ($781.66K)	Conroy Kevin T President and CEO Director		EXACT Sciences Corp. - EXAS	4% 998.34K to 1.04M	0	0	--	--	Show Txns Hide Txns

03-Mar-20 7:20 PM View:	28-Feb-20 Sale (Planned) ($155.08K)	Doyle James Edward Director		EXACT Sciences Corp. - EXAS	(6%) 34.44K to 32.44K	0	0	--	--	Show Txns Hide Txns

02-Mar-20 7:15 PM View:	28-Feb-20 Planned Option Sale ($191.04K)	Elliott Jeffrey Thomas Chief Financial Officer		EXACT Sciences Corp. - EXAS	17% 51.06K to 59.73K	0	0	--	--	Show Txns Hide Txns

28-Feb-20 4:39 PM View:	27-Feb-20 Planned Option Sale ($84.36K)	Stenhouse Mark President, Cologuard		EXACT Sciences Corp. - EXAS	15% 14.66K to 16.87K	0	0	--	--	Show Txns Hide Txns

Yesterday 4:15 PM View:	15-Feb-20 Option Exercise 0	Hoof Torsten General Manager, International		EXACT Sciences Corp. - EXAS	55% 3.82K to 5.91K	0	0	--	--	Show Txns Hide Txns

20-Feb-20 5:55 PM View:	19-Feb-20 Market Option Sale (Planned) ($116.08K)	Orville Jacob A General Manager, New Ventures		EXACT Sciences Corp. - EXAS	1299% 0.19K to 2.69K	0	($116.08K) (601%)	--	$100.68	Show Txns Hide Txns

21-Feb-20 4:58 PM View:	19-Feb-20 Market Sale (Planned) ($1,000.00K)	Cole G Bradley General Manager - Diagnostics		EXACT Sciences Corp. - EXAS	(67%) 30.99K to 10.19K	0	($2.74M) (88%)	--	$100.00	Show Txns Hide Txns